Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Australian Pharmaceutical Industries Limited (ASX: API) - Share Price and Research
DELISTED - Current share price for API : $1.530
API General Information +
| ASX Code | API |
| Website | N/A |
| Industry/Sector | Health Care Distributors |
| Market Cap ($M) | n/a |
| API Share Price | $1.530 |
| Day High | $1.530 |
| Day Low | $1.528 |
| Last Close | $1.530 |
| API Share Price Movement | - ( No change ) |
Prices as at 16:36, 4 Apr 2022
+Security prices are delayed by at least 20 minutes and are indicative only.
Recommendation
Australian Pharmaceutical Industries Limited - API
Current price
$1.53 at 16:36 (04 April 2022)
Price at review
$1.53 at (22 March 2022)
Business Risk
Share Price Risk
All Prices are in AUD ($)
API Related Research
Australian Pharmaceutical Industries Limited (API) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 3¢ | 100% | 24 Mar 2022 | 29 Mar 2022 | $1.530 | $1.530 | 2.29% |
| HFResult | 2¢ | 100% | 11 Nov 2021 | 15 Dec 2021 | $1.530 | $1.530 | 2.29% |
| Result | 1.5¢ | 100% | 6 May 2021 | 4 Jun 2021 | $1.530 | $1.530 | 2.29% |
See all dividends from Australian Pharmaceutical Industries Limited (API) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Australian Pharmaceutical Industries Limited (API) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Removal from Official List | 1 Apr 2022 9:02AM | $1.530 | $1.530 | $1.530 | fallen by 0% |
| WES: Completion of API acquisition | 31 Mar 2022 3:03PM | $1.530 | $1.530 | $1.530 | fallen by 0% |
| Implementation of Scheme of Arrangement | 31 Mar 2022 2:31PM | $1.530 | $1.530 | $1.530 | fallen by 0% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Australian Pharmaceutical Industries Limited (API) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
API Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Richard Craig Vincent | Chief Executive Officer, Managing Director | 15 Feb 2017 |
Australian Pharmaceutical Industries Limited (API) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 29 Mar 2022 | VINCENT, Richard | Cancelled | Related Securities | 2,213,741 | $1.550 | $3,431,298.550 |
| 14 Dec 2020 | MACDONALD, Jennifer (Jenny) | Buy | Direct Shares | 25,000 | $1.305 | $32,625.000 |
| 24 Apr 2020 | SMITH, Mark | Buy | Indirect Shares | 40,000 | $1.039 | $41,550.000 |
See all changes in directors' interest & trades for Australian Pharmaceutical Industries Limited (API) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
API Management
| Name | Position |
|---|---|
| Peter Mendo | Chief Financial Officer |
| Anne Mustow | Company Secretary,General Counsel |
API Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (API). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 95,068,472 (19.08%) | Wesfarmers Limited |
| 38,360,947 (7.70%) | Mitsubishi UFJ Financial Group, Inc |
| 38,359,203 (7.70%) | First Sentier Investors Holdings Pty Ltd |
FAQs about Australian Pharmaceutical Industries Limited (API)
What is the current share price of Australian Pharmaceutical Industries Limited (API)?
Australian Pharmaceutical Industries Limited's (API) current share price is $1.53. This constitutes a price movement of 0% when compared to the share price 7 days ago and is n/a below API's 12-month high of n/a per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Australian Pharmaceutical Industries Limited (API)?
Relative to the previous close share price of $1.53, Australian Pharmaceutical Industries Limited's (API) current share price of $1.53 constitutes a movement of or 0%. Australian Pharmaceutical Industries Limited's (API) share price movement is 0% when compared to 7 days ago and is n/a below API's 52-week high of n/a.
What is the dividend yield for Australian Pharmaceutical Industries Limited (API)?
Australian Pharmaceutical Industries Limited (API) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for API is a ratio that tells you the percentage of Australian Pharmaceutical Industries Limited's (API) share price that it pays out in dividends each year.
What was Australian Pharmaceutical Industries Limited (API) last dividend payment?
Australian Pharmaceutical Industries Limited (API) last dividend payment was $0.03 per share and was paid on 29 Mar 2022. This last API dividend included 100% franking.
When does Australian Pharmaceutical Industries Limited (API) release its next Annual Report?
Australian Pharmaceutical Industries Limited (API) will release its next Annual Report on n/a. Australian Pharmaceutical Industries Limited's (API) last annual report was released on 15 Dec 2021. Click here to view Australian Pharmaceutical Industries Limited's (API) last annual report.
In which sector is Australian Pharmaceutical Industries Limited (API) classified?
Australian Pharmaceutical Industries Limited (API) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
